financetom
Business
financetom
/
Business
/
United Flies Past Earnings Estimates, Revenue And Guidance Hit Headwinds
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Flies Past Earnings Estimates, Revenue And Guidance Hit Headwinds
Jul 17, 2025 8:40 AM

Shares of United Airlines Holdings Inc ( UAL ) rallied in early trading on Thursday, after the company reported upbeat second-quarter earnings.

The announcement came amid an exciting earnings season. Here are some key analyst takeaways.

BofA Securities analyst Andrew Didora reiterated a Buy rating and price target of $90.

Raymond James analyst Savanthi Syth maintained a Market Perform rating on the stock.

Check out other analyst stock ratings.

BofA Securities: United Airlines reported strong earnings of $3.87 per share, beating Street expectations of $3.84 per share, Didora said in a note. The company managed to beat earnings despite the Newark disruption and flight cancellations due to the Middle East tensions, he added.

The performance was driven by premium cabin exposure, which "continues to differentiate UAL from most airlines," the analyst stated. Management's outlook for the third quarter and full year came in-line with expectations, indicating the company's "conservatism around guidance and the power of its business model," he further wrote.

Raymond James: United Airlines' revenue contracted on a year-on-year basis and came in below the consensus estimates, Syth said. The company's pretax margin, at 11.0%, was slightly lower than Delta Air Lines Inc's ( DAL ) 11.6%, he added.

Management lowered their 2025 earnings guidance from $11.50-13.50 per share to $9.00-11.00 per share, while reiterating the capex outlook, the analyst stated. "Notably, beginning in early July, United has seen a sequential 6 ppt acceleration in demand vs. 2Q25 indicating that forward booking might be reaching demand levels consistent with earlier in the year," he further wrote.

UAL Price Action: Shares of United Airlines had risen by 2.82% to $90.79 at the time of publication on Thursday.

Read More:

Delta Air Lines Stock Rallies on New Guidance—Can It Keep Going?

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Dalata Hotel Group plc
Form 8.3 - Dalata Hotel Group plc
Oct 28, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed,...
Soma Gold Reports
Soma Gold Reports "Positive" Ore Sorting Results From Cordero Mine, Colombia
Oct 28, 2025
09:38 AM EDT, 10/28/2025 (MT Newswires) -- Soma Gold ( SMAGF ) Tuesday reported positive results from a preliminary Ore Sorting study conducted on a bulk sample of mineralized material from the Cordero Mine in Antioquia, Colombia. The company said a series of calibration samples, representing four grade bins, was scanned with four standard sensors. This data was used to...
Microsoft Stock Moves Higher On New Deal With OpenAI
Microsoft Stock Moves Higher On New Deal With OpenAI
Oct 28, 2025
Microsoft Corp ( MSFT ) shares are trading higher Tuesday morning after the company announced the next chapter of its partnership with OpenAI. MSFT is charging ahead with explosive momentum. Get the market research here. What To Know: Microsoft ( MSFT ) signed a new definitive agreement with OpenAI to support the company’s formation of a public benefit corporation (PBC). Following the...
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks
Oct 28, 2025
Oct 28 (Reuters) - The makers of Tylenol, Johnson & Johnson ( JNJ ) and Kenvue, were sued on Tuesday by Texas Attorney General Ken Paxton, who accused them of knowingly hiding the drug's links to autism and attention deficit hyperactivity disorder. Paxton, a Republican, sued five weeks after Republican President Donald Trump said using Tylenol during pregnancy can cause...
Copyright 2023-2026 - www.financetom.com All Rights Reserved